SCHEMBL3389559

SCHEMBL3389559

COC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 1/20 0.62
▸ NAALAD2 Q9Y3Q0 1/20 0.58
▸ MME P08473 6/20 0.57
▸ ACE P12821 6/20 0.57
▸ CPA1 P15085 1/20 0.57
▸ ACE2 Q9BYF1 1/20 0.57
▸ CA1 P00915 1/20 0.52
▸ CA2 P00918 1/20 0.52
▸ CTSS P25774 1/20 0.52
▸ CTSK P43235 1/20 0.52
▸ ITGA4 P13612 1/20 0.52
▸ ITGB7 P26010 1/20 0.52
▸ TSHR P16473 1/20 0.50
▸ LNPEP Q9UIQ6 1/20 0.50
▸ MDM4 O15151 1/20 0.50
▸ MDM2 Q00987 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13413401 1.00 FOLH1 (0.62) FOLH1NAALAD2MMEACECPA1
SCHEMBL22804066 1.00 FOLH1 (0.62) FOLH1NAALAD2MMEACECPA1
Benzene SCHEMBL27572323 0.98 FOLH1 (0.61) FOLH1NAALAD2MMEACECPA1
Benzene SCHEMBL28748036 0.98 FOLH1 (0.61) FOLH1NAALAD2MMEACECPA1
Benzene SCHEMBL27572324 0.98 FOLH1 (0.61) FOLH1NAALAD2MMEACECPA1
SCHEMBL17931626 0.87 L3MBTL1 (0.52) FOLH1MMEACECPA1ACE2
SCHEMBL12159572 0.87 ITGA4 (0.52) FOLH1MMEACECPA1ACE2
SCHEMBL14274289 0.87 LNPEP (0.50) FOLH1NAALAD2MMEACECPA1
SCHEMBL2519897 0.87 NPSR1 (0.61) CTSSCTSKTSHRLNPEPMDM4
SCHEMBL754129 0.87 MME (0.59) NAALAD2MMEACECPA1ACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115053184-A Composition for forming EUV resist underlayer film 日产化学株式会社 2022-09-13 — — CN disclosed
WO-2020252713-A1 MODIFIED HYDROPHOBIC AUXILIARY MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF 浙江智达药业有限公司 2020-12-24 — — WO disclosed
US-8524657-B2 Peptidic compounds UNIVERSITY OF WOLLONGONG (AU) 2013-09-03 — — US disclosed
EP-1836159-B1 Antibiotic binaphthyl derivatives UNIV WOLLONGONG (AU) 2013-04-10 — — EP disclosed
US-20110312875-A1 PEPTIDIC COMPOUNDS UNIVERSITY OF WOLLONGONG (AU) 2011-12-22 — — US disclosed
EP-2199300-A2 Peptidic compounds The University Of Wollongong (AU) 2010-06-23 — — EP disclosed
EP-1836159-A4 PEPTIDIC COMPOUNDS UNIV WOLLONGONG (AU) 2009-02-25 — — EP disclosed
EP-1836159-A1 PEPTIDIC COMPOUNDS UNIVERSITY OF WOLLONGONG (AU) 2007-09-26 — — EP disclosed
WO-2006074501-A1 PEPTIDIC COMPOUNDS UNIVERSITY OF WOLLONGONG (AU) 2006-07-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312875-A1 PEPTIDIC COMPOUNDS VIP, NGLY1, FURIN FOLH1 271/4885NAALAD2 456/4885MME 70/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback